• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERGE HEALTHCARE MERGE HEMODYNAMICS; PROGRAMMABLE DIAGNOSTIC COMPUTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERGE HEALTHCARE MERGE HEMODYNAMICS; PROGRAMMABLE DIAGNOSTIC COMPUTER Back to Search Results
Model Number MERGE HEMODYNAMICS 10.0.1
Device Problems Application Program Problem (2880); Blocked Connection (2888)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/10/2016
Event Type  malfunction  
Manufacturer Narrative
The customer's reported problem is currently under investigation by (b)(4) healthcare.For this reason, conclusions code (conclusion not yet available-evaluation in progress) was used.When more information becomes available, a supplemental report will be submitted.
 
Event Description
Merge hemodynamics monitors, measures, and records physiological data from a human patient undergoing a cardiac catheterization procedure.The system comprises the patient data module and the merge hemodynamics hemo monitor pc.The two units are connected via a serial interface.All vital parameters and evaluations are registered and calculated in the patient data module.This data is then transmitted to the merge hemodynamics hemo monitor pc via the serial interface.All data can be shown and monitored on the merge hemodynamics hemo monitor pc.On (b)(6) 2016, a customer reported to merge healthcare that problems were experienced in the middle of a procedure after active monitoring and sedation had been initiated.Subsequently, the hemo monitor was rebooted that resulted in a loss of patient monitoring.The delay was approximately 10-15 minutes while the hemo system rebooted.With merge hemo not capturing physiological data, there is a potential for delay in treatment that could cause harm to the patient.However, the customer reported that the procedure was completed successfully once the hemo monitor was rebooted.Reference complaint number (b)(4).
 
Manufacturer Narrative
This supplemental report is submitted to the fda in accordance with the applicable regulations and as indicated by merge healthcare in the initial report submitted 29dec2016.During troubleshooting efforts between the customer and merge technical support, the customer reported that the hemo monitor was rebooted in the site's cath lab 2 and this corrected the issue.The procedure in progress was completed successfully in this same lab.However, the customer called in two (2) subsequent times to report a similar issue in the same lab.Reference (b)(4) and (b)(4).A review of the customer's hemo case management within merge healthcare's internal database on (b)(6) 2018 confirmed that there have been no further issues reported by the customer to merge healthcare concerning an issue requiring a reboot of the hemo monitor since the last occurrence cited above.Device labeling, hemo-6373 v10 user manual, addresses the potential for a loose cable connection in the troubleshooting section with statements such as, "problem: there is no communication between hemo monitor pc and client.Resolution: check that the crossover cable from the client to the hemo monitor is plugged in properly and lights are on.Reboot the hemo monitor pc.Exit and reopen the study.Answer yes to is patient still being monitored.Check that the client is properly configured to use the hemo monitor pc (in system config).If none of these work, contact technical support." no further actions are anticipated at this time due to the issue being readily apparent to the user, the non-serious injury assessment to a patient, and the instructions provided to the user on what to do if this situation were to occur.Revised information contained in this supplemental report includes the following: g1-2 - updated contact office - name/address.G4 - date new information received by manufacturer (case closure date).G7 - indication that this is follow-up report 1.H1 - indication of malfunction as reportable event.H2 - indication of additional information and device evaluation.H6 - evaluation codes: methods code: 3263 - actual device not evaluated.Results code: 3213 - interoperability problem (a problem with the mechanical, electrical, or communication interface between two or more separate devices or components).Conclusions code: 13 - device difficult to operate.H10 - indication of additional manufacturer information and corrected data are contained in this follow-up report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MERGE HEMODYNAMICS
Type of Device
PROGRAMMABLE DIAGNOSTIC COMPUTER
Manufacturer (Section D)
MERGE HEALTHCARE
900 walnut ridge drive
hartland WI 53029
MDR Report Key6214996
MDR Text Key63616072
Report Number2183926-2016-00826
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
PMA/PMN Number
K082421
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 11/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMERGE HEMODYNAMICS 10.0.1
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/29/2016
Initial Date FDA Received12/29/2016
Supplement Dates Manufacturer Received02/10/2017
Supplement Dates FDA Received05/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-